EcoDrugPlus

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSBBBG00000007384
Gene Symbol: CRHR1
3 Cross references
208 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSBBBG00000014079
Gene Symbol: CDK1
3 Cross references
245 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSBBBG00000014128
Gene Symbol: CDK2
3 Cross references
200 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSBBBG00000011463
Gene Symbol: CDK4
2 Cross references
231 Possible Orthologues:

Cyclin Dependent Kinase 5

Ensembl ID : ENSBBBG00000003543
Gene Symbol: CDK5
3 Cross references
169 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSBBBG00000018101
Gene Symbol: CDK6
3 Cross references
201 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSBBBG00000013204
Gene Symbol: CDK7
3 Cross references
219 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSBBBG00000020831
Gene Symbol: CDK9
3 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSBBBG00000016054
Gene Symbol: CYSLTR1
3 Cross references
181 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSBBBG00000015999
Gene Symbol: CDA
3 Cross references
232 Possible Orthologues:

Cytochrome P450 3a24

Ensembl ID : ENSBBBG00000010568
Gene Symbol: LOC104992730
2 Cross references
697 Possible Orthologues:

Cytochrome P450 3a24-Like

Ensembl ID : ENSBBBG00000001861
Gene Symbol: LOC104992731
2 Cross references
699 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).